Scotland · NHS Scotland MSAN
Trandate® (labetalol) 50mg tablets
MSAN(2024)60 · Level 2 · issued 16 Oct 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Valid until: product to be discontinued from July 2025 | Discontinued | — |
| 1. Trandate® (labetalol) 50mg tablets will be discontinued from July 2025. | Discontinued | — |
| 2. Alternative low dose beta-blockers remain available. Where these are not suitable, UK | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2024:60
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
c3d5acd56d9b31655118bc81ea94883b17e3a569ade2b815eb499c14bacb9222sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2024-60.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.